LY2801653

LY2801653 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY2801653, covering 2014-01-09 to 2015-06-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children [Phase 1]